Nanocomposix, Llc
CAGE Code: 3ZAN8
NCAGE Code: 3ZAN8
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 159070825
Summary
Nanocomposix, Llc is an Active Commercial Supplier with the Cage Code 3ZAN8 and is tracked by Dun & Bradstreet under DUNS Number 159070825..
Address
4878 Ronson Ct
San Diego CA 92111-1806
United States
Points of Contact
Related Information
People who viewed this 'CAGE Code' also viewed...
Technet Jarecki Engineering Circle Intl Temple Ralph Corona Consulting Btg Technology Systems Quality Technology Services, Inc. P&D Consultants Inc. Nova Commercial Co Inc Precision Metal Products Co Frut Stix Co Div Of Lafayette Foods Lynx Systems Kjos Neil A Music Co Circle M Construction Lopez Dunn Ramirez And Associates Morton Equipment And Supply Company G G B Drywall Co Ocean Sensors Inc King Communications Compucom Systems Inc
Frequently Asked Questions (FAQ) for CAGE 3ZAN8
- What is CAGE Code 3ZAN8?
- 3ZAN8 is the unique identifier used by NATO Organizations to reference the physical entity known as Nanocomposix, Llc located at 4878 Ronson Ct, San Diego CA 92111-1806, United States.
- Who is CAGE Code 3ZAN8?
- 3ZAN8 refers to Nanocomposix, Llc located at 4878 Ronson Ct, San Diego CA 92111-1806, United States.
- Where is CAGE Code 3ZAN8 Located?
- CAGE Code 3ZAN8 is located in San Diego, CA, USA.
Contracting History for CAGE 3ZAN8 Most Recent 25 Records
- 75D30122P15630
- Lateral Flow Assay Devices
- 28 Sep 2022
- Lateral Flow Assay Devices
- Cdc Office Of Acquisition Services
- Department Of Health And Human Services (Hhs)
- $300,000.00
- Department Of Health And Human Services (Hhs)
- 75D30121P12824
- Lateral Assay Device
- 14 Dec 2021
- Lateral Assay Device
- Cdc Office Of Acquisition Services
- Department Of Health And Human Services (Hhs)
- $249,950.00
- Department Of Health And Human Services (Hhs)
- 75D30121P12824
- Lateral Assay Device
- 22 Sep 2021
- Lateral Assay Device
- Cdc Office Of Acquisition Services
- Department Of Health And Human Services (Hhs)
- $249,950.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00013
- The Objective Of This Contract Is To Design And Synthesis A New Plga Based Nanoparticle With Nanoparticle With Optimal Protein-Adjuvant Formulation Combining Both Targeting And Controlled Delivery For Immunization Against Hiv.
- 16 May 2022
- The Objective Of This Contract Is To Design And Synthesis A New Plga Based Nanoparticle With Nanoparticle With Optimal Protein-Adjuvant Formulation Combining Both Targeting And Controlled Delivery For Immunization Against Hiv.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $300,000.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00013
- The Objective Of This Contract Is To Design And Synthesis A New Plga Based Nanoparticle With Nanoparticle With Optimal Protein-Adjuvant Formulation Combining Both Targeting And Controlled Delivery For Immunization Against Hiv.
- 13 Sep 2022
- The Objective Of This Contract Is To Design And Synthesis A New Plga Based Nanoparticle With Nanoparticle With Optimal Protein-Adjuvant Formulation Combining Both Targeting And Controlled Delivery For Immunization Against Hiv.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $300,000.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00013
- Eo14042: The Objective Of This Contract Is To Design And Synthesis A New Plga Based Nanoparticle With Nanoparticle With Optimal Protein-Adjuvant Formulation Combining Both Targeting And Controlled Delivery For Immunization Against Hiv.
- 29 Nov 2021
- Eo14042: The Objective Of This Contract Is To Design And Synthesis A New Plga Based Nanoparticle With Nanoparticle With Optimal Protein-Adjuvant Formulation Combining Both Targeting And Controlled Delivery For Immunization Against Hiv.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $300,000.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00030
- Extend The Performance Time
- 28 Jul 2022
- Extend The Performance Time
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $1,500,000.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00030
- The Objective Is To Develop Cmv Igg And Igm Lateral Flow Assays Required To Support A Large Scale Cmv Vaccination Trial.
- 31 Jul 2019
- The Objective Is To Develop Cmv Igg And Igm Lateral Flow Assays Required To Support A Large Scale Cmv Vaccination Trial.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $1,500,000.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00030
- This Award Is Hereby Modified To Incorporate Hhsar 352.232-71 Electronic Submission Of Payment Requests In Full Text And Provide Instructions For The Transition From The Nih Office Of Financial Management (Ofm) Electronic Invoice Submission To The
- 11 Apr 2023
- This Award Is Hereby Modified To Incorporate Hhsar 352.232-71 Electronic Submission Of Payment Requests In Full Text And Provide Instructions For The Transition From The Nih Office Of Financial Management (Ofm) Electronic Invoice Submission To The
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $1,500,000.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00030
- This Award Is Hereby Modified To Incorporate Hhsar 352.232-71 Electronic Submission Of Payment Requests In Full Text And Provide Instructions For The Transition From The Nih Office Of Financial Management (Ofm) Electronic Invoice Submission To The
- 28 Jul 2022
- This Award Is Hereby Modified To Incorporate Hhsar 352.232-71 Electronic Submission Of Payment Requests In Full Text And Provide Instructions For The Transition From The Nih Office Of Financial Management (Ofm) Electronic Invoice Submission To The
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $1,500,000.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00030
- The Objective Is To Develop Cmv Igg And Igm Lateral Flow Assays Required To Support A Large Scale Cmv Vaccination Trial.
- 13 Sep 2021
- The Objective Is To Develop Cmv Igg And Igm Lateral Flow Assays Required To Support A Large Scale Cmv Vaccination Trial.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $1,500,000.00
- Department Of Health And Human Services (Hhs)
- W81XWH17C0189
- Igf::Ct::Igf Sbir Phase Ii Tasking
- 18 Sep 2017
- Igf::Ct::Igf Sbir Phase Ii Tasking
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $1,000,000.00
- Department Of Defense (Dod)
- 75N92B23P00004
- Nanocomposix Inc:1166666 [23-000212]
- 26 Oct 2022
- Nanocomposix Inc:1166666 [23-000212]
- Nih Niams
- Department Of Health And Human Services (Hhs)
- $15,025.00
- Department Of Health And Human Services (Hhs)
- W911SR20C0033
- Nanocomposix, Inc. To Develop Drying Processes For Producing High Aspect Ratio Conductive Flakes Using Physical Vapor Deposition.
- 19 May 2020
- Nanocomposix, Inc. To Develop Drying Processes For Producing High Aspect Ratio Conductive Flakes Using Physical Vapor Deposition.
- W6qk Acc-Apg
- Department Of Defense (Dod)
- $111,500.00
- Department Of Defense (Dod)
- 75F40122P00453
- Production Of Aunp For Drug Delivery To The Cns To Monitor Efficacy And Safety
- 13 Sep 2022
- Production Of Aunp For Drug Delivery To The Cns To Monitor Efficacy And Safety
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $25,025.00
- Department Of Health And Human Services (Hhs)
- 75F40122P00454
- Production Of Aunp For In Vivo Analysis Of Bbb Safety And Integrity
- 13 Sep 2022
- Production Of Aunp For In Vivo Analysis Of Bbb Safety And Integrity
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $25,025.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00013
- The Objective Of This Contract Is To Generate An Effective Hiv Vaccine Using The Targeted And Controlled Delivery Of Antigens To Antigen Presenting Cells (Apc). Engineered Nanoparticles Loaded With Mrna Captured Behind Ph Sensitive Polymer, Targeted
- 1 Apr 2022
- The Objective Of This Contract Is To Generate An Effective Hiv Vaccine Using The Targeted And Controlled Delivery Of Antigens To Antigen Presenting Cells (Apc). Engineered Nanoparticles Loaded With Mrna Captured Behind Ph Sensitive Polymer, Targeted
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $600,000.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00013
- The Objective Of This Contract Is To Generate An Effective Hiv Vaccine Using The Targeted And Controlled Delivery Of Antigens To Antigen Presenting Cells (Apc). Engineered Nanoparticles Loaded With Mrna Captured Behind Ph Sensitive Polymer, Targeted
- 10 Jun 2021
- The Objective Of This Contract Is To Generate An Effective Hiv Vaccine Using The Targeted And Controlled Delivery Of Antigens To Antigen Presenting Cells (Apc). Engineered Nanoparticles Loaded With Mrna Captured Behind Ph Sensitive Polymer, Targeted
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $600,000.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00013
- Eo14042 The Objective Of This Contract Is To Generate An Effective Hiv Vaccine Using The Targeted And Controlled Delivery Of Antigens To Antigen Presenting Cells (Apc). Engineered Nanoparticles Loaded With Mrna Captured Behind Ph Sensitive Polymer.
- 9 Dec 2021
- Eo14042 The Objective Of This Contract Is To Generate An Effective Hiv Vaccine Using The Targeted And Controlled Delivery Of Antigens To Antigen Presenting Cells (Apc). Engineered Nanoparticles Loaded With Mrna Captured Behind Ph Sensitive Polymer.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $600,000.00
- Department Of Health And Human Services (Hhs)
- W911NF17P0041
- Igf::Ot::Igf:: Phase I First Monthly Technical Report--
- 20 Dec 2017
- Igf::Ot::Igf:: Phase I First Monthly Technical Report--
- W6qk Acc-Apg Durham
- Department Of Defense (Dod)
- $150,000.00
- Department Of Defense (Dod)
- 75N92B23P00011
- Nanocomposix Inc:1166666 [23-000622]
- 5 Dec 2022
- Nanocomposix Inc:1166666 [23-000622]
- Nih Niams
- Department Of Health And Human Services (Hhs)
- $15,025.00
- Department Of Health And Human Services (Hhs)